Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Podcasting since 2022 • 178 episodes
Beyond Biotech - the podcast from Labiotech
Latest Episodes
Johnson & Johnson’s hematology portfolio: breakthroughs to watch
Welcome to our final episode for 2025. We’re taking a little break for the holidays but we’ll be back again on Friday 9th of January to kick off our year with the Managing Director of Merck KGaA’s M Ventures, Hakan Goker.Today, though, I...
•
Episode 178
•
34:25
Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach
In this episode we sit down with Martin Beck, Senior Vice President and Head of the Inflammation Business Unit at Boehringer Ingelheim. Martin grew up just down the road from the company’s h...
•
Episode 177
•
38:47
Cracking Cancer’s Code: Transforming Research with Novel Cancer Models
Cancer is one of the biggest health challenges worldwide. While progress has been made, millions of patients are still in need of new treatment options that better address the complexities of their disease.BeOne Medicines is creating the...
•
Episode 176
•
29:47
Curing cancer: Daiichi Sankyo's ambitious ADC approach
Daiichi Sankyo has been pioneering ADCs since 2010, with a pipeline targeting over 30 indications and potentially reaching 400,000 patients.In today’s episode I’m joined by Dr. Markus Kosch, Head of the EU Oncology Business Division at D...
•
Episode 175
•
39:42
How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes
Two weeks ago, the biopharma industry gathered in Vienna, Austria, for BIO-Europe. Tens of thousands of one-on-one meetings were organized between innovators and out-licensors with top pharma companies and venture capitalists eager to partner a...
•
Episode 174
•
28:23